Plasmodium Vivax

12 registered clinical trials studyying Plasmodium Vivax — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar NCT06923592	London School of Hygiene and Tropical Medicine	Phase 3
Completed	Vivax Elimination With Tafenoquine (VET) Study NCT06575647	Shoklo Malaria Research Unit	Phase 4
Completed	Phenotyping and Genotyping of Duffy Antigen NCT05527119	University Hospital, Strasbourg, France	—
Completed	Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine NCT04411836	Menzies School of Health Research	Phase 3
Terminated	The Malaria Heart Disease Study NCT04445103	University Hospital, Gentofte, Copenhagen	—
Active Not Recruiting	Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar NCT06392152	Pyae Linn Aung	N/A
Completed	P.Vivax Treatment Trial NCT02802813	University of Oxford	Phase 1 / Phase 2
Unknown	Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam NCT02610686	National Institute of Malariology, Parasitology and Entomology, Vietnam	Phase 4
Completed	Phase Ia Study of ChAd63/MVA PvDBP NCT01816113	University of Oxford	Phase 1
Completed	Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults NCT01157897	U.S. Army Medical Research and Development Command	Phase 1 / Phase 2
Unknown	Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection NCT02364583	Papua New Guinea Institute of Medical Research	Phase 4
Terminated	Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults NCT01290601	U.S. Army Medical Research and Development Command	Phase 2